Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab

Authors

  • Mingxia Wang
  • Qi Zheng
  • Suwei Tang
  • Fang Shen
  • Wenchen Jiang Department of TCM Dermatology, Shanghai Dermatology Hospital, Tongji University School of Medicine, Shanghai 200443, China

DOI:

https://doi.org/10.2340/actadv.v102.2245

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Ariëns LFM, van der Schaft J, Stades AME, van de Woestijne AA, De Bruin-Weller MS. Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids. Acta Derm Venereol 2018; 98: 601.

https://doi.org/10.2340/00015555-2936 DOI: https://doi.org/10.2340/00015555-2936

Steve C. Dupilumab for the treatment of atopic dermatitis. Prescriber 2018; 29: 35-37.

https://doi.org/10.1002/psb.1675 DOI: https://doi.org/10.1002/psb.1675

Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 2016; 375: 2335-2348.

https://doi.org/10.1056/NEJMoa1610020 DOI: https://doi.org/10.1056/NEJMoa1610020

de Wijs LEM, Bosma AL, Erler NS, Hollestein LM, Gerbens LAA, Middelkamp-Hup MA, et al. Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data. Br J Dermatol 2020; 182: 418-426.

https://doi.org/10.1111/bjd.18179 DOI: https://doi.org/10.1111/bjd.18179

Thomson J, Wernham AGH, Williams HC. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal. Br J Dermatol 2018; 178: 897-902.

https://doi.org/10.1111/bjd.16317 DOI: https://doi.org/10.1111/bjd.16317

Lommatzsch M, Stoll P, Winkler J, Zeise-Wehry D, Tronnier M, Weber MA, Virchow JC. Eosinophilic pleural effusion and stroke with cutaneous vasculitis: two cases of dupilumab-induced hypereosinophilia. Allergy 2021; 76: 2920-2923.

https://doi.org/10.1111/all.14964 DOI: https://doi.org/10.1111/all.14964

Changsha Jia, Yongyan Chen, Wen Yan, et al. A case of purpura drug eruption. The Chin J Dermatovenereol 2016; 30: 397-399.

Frey S, Kendziora B, Holch JW, Lindner L, French LE, Wollenberg A. Immune thrombocytopenic purpura in a patient with atopic dermatitis treated with dupilumab. Acta Derm Venereol 2021; 101: adv00409.

https://doi.org/10.2340/00015555-3734 DOI: https://doi.org/10.2340/00015555-3734

Young JWS, Shear NH. Cutaneous drug reactions in the elderly. Drugs Aging 2017; 34: 655-672.

https://doi.org/10.1007/s40266-017-0483-5 DOI: https://doi.org/10.1007/s40266-017-0483-5

Published

2022-06-29

How to Cite

Wang, M., Zheng, . Q., Tang, S., Shen, F., & Jiang, W. (2022). Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab. Acta Dermato-Venereologica, 102, adv00744. https://doi.org/10.2340/actadv.v102.2245